TELMIJUB AM 40/5MG TABLET is used in the management of hypertension. It is preferably used when treatment with single BP medicines does not provide adequate control in blood pressure.
It contains a combination of two medicines, namely Amlodipine and Telmisartan which works by relaxing the blood vessels supplying the heart and other organs which reduces the strain on the heart and decreases blood pressure.
Take TELMIJUB AM 40/5MG TABLET under medical supervision. It can be taken with or without meals. Do not take alcohol or grapefruit juice while taking TELMIJUB AM 40/5MG TABLET, as it could severely decrease your blood pressure.
Before taking TELMIJUB AM 40/5MG TABLET inform your doctor if you have any liver disease, kidney disease or any other heart conditions apart from hypertension such as heart failure, etc. You must also inform your doctor if have diabetes, swelling of body parts or any other pre-existing medical conditions.
Do not take TELMIJUB AM 40/5MG TABLET without consulting your doctor if you are pregnant and breastfeeding as a precaution. The most common side effects of taking TELMIJUB AM 40/5MG TABLET are dizziness, tiredness, sleepiness, sudden drop in blood pressure with fainting, racing heartbeat, and flushing or redness of face and neck. Talk to your doctor if any of these side effects trouble you.
TELMIJUB AM 40/5MG TABLET is a combination of two medications namely, amlodipine and telmisartan. Amlodipine is a calcium channel blocker that works by relaxing the blood vessels and improving blood flow by preventing calcium from entering the muscles of the heart and arteries, which helps to lower blood pressure. Telmisartan is an angiotensin II receptor blocker (ARB), which blocks the hormone angiotensin II, preventing it from tightening blood vessels. This also helps relax the blood vessels and reduce blood pressure. Together, these two drugs provide better control of high blood pressure.
Stop taking TELMIJUB AM 40/5MG TABLET and inform your doctor immediately if you experience any of the following side effects such as:
Studies have shown that telmisartan can harm the growing baby. Therefore, the combination of amlodipine and telmisartan is not preferrable for use in pregnant women. Women of childbearing potential must avoid getting pregnant while taking TELMIJUB AM 40/5MG TABLET.
Studies have shown that the combination of amlodipine and telmisartan may pass through breast milk. Therefore, it is not recommended for use in breastfeeding women.
Do not drive or handle heavy tools or machines if your ability is affected by TELMIJUB AM 40/5MG TABLET.
Avoid consumption of alcohol while taking TELMIJUB AM 40/5MG TABLET as it could make your dizzier.
TELMIJUB AM 40/5MG TABLET should be used with caution in patients having kidney problems.
TELMIJUB AM 40/5MG TABLET should be used with caution in patients having liver problems.
Do not take TELMIJUB AM 40/5MG TABLET if you are allergic to Amlodipine and Telmisartan.
TELMIJUB AM 40/5MG TABLET should not be used in patients with severely decreased blood pressure. It should be used with caution in patients suffering from other heart problems such as heart attack, severe hypertensive crisis, etc,
It is not known whether the combination of amlodipine and telmisartan is safe for use in children aged below 18 years. Therefore, consult your doctor for advice.
TELMIJUB AM 40/5MG TABLET should be used with caution in elderly patients (aged 65 years or more), especially if suffering from kidney problems.
Before taking TELMIJUB AM 40/5MG TABLET, inform your doctor if you:
A. Drug-Drug interactions:
Overdosage:
If you or anyone else accidentally take too much of TELMIJUB AM 40/5MG TABLET, consult your doctor immediately or visit the nearby hospital.
Drug | : | Amlodipine, Telmisartan |
Pharmacological Category | : | Calcium Channel Blockers, Angiotensin Receptor Blockers |
Therapeutic Indication | : | Hypertension, Angina |
Dosage Forms | : | Tablet |
To know more about this medicine:
A: TELMIJUB AM 40/5MG TABLET is used in the management of hypertension.
A: TELMIJUB AM 40/5MG TABLET is an antihypertensive medicine. It is a combination of two medicines namely amlodipine and telmisartan. Amlodipine is a calcium channel blocker and telmisartan is an angiotensin-II receptor blocker. They both reduce strain on the heart, relaxes blood vessels and makes the heart to pump more blood with lesser force.
A: Do not stop taking TELMIJUB AM 40/5MG TABLET without consulting your doctor as your blood pressure may raise again. Make sure to take TELMIJUB AM 40/5MG TABLET for the stipulated duration recommended by your doctor to achieve maximum results.
A: TELMIJUB AM 40/5MG TABLET can be taken with or without meals. Your doctor will decide the best time for you to take TELMIJUB AM 40/5MG TABLET based on your age, body weight and disease condition.
A: Before taking TELMIJUB AM 40/5MG TABLET inform your doctor if you have any heart, liver or kidney problems. You must also inform your doctor if you have diabetes, low blood pressure volume or are severely dehydrated. Stop taking TELMIJUB AM 40/5MG TABLET and consult your doctor immediately if you become pregnant. Regularly visit your doctor and take all the necessary blood test recommended by your doctor without fail.
A: Avoid consumption of alcohol while taking TELMIJUB AM 40/5MG TABLET as it might make you feel dizzier and drowsier.
A: If you or anyone else accidentally took more TELMIJUB AM 40/5MG TABLET, consult your doctor immediately. Overdosage may cause low blood pressure, abnormal heartbeat, fainting, drowsiness, nausea, vomiting or confusion.
A: Take TELMIJUB AM 40/5MG TABLET as advised by your physician. Your doctor will evaluate your health condition and suggests whether can you take TELMIJUB AM 40/5MG TABLET every day or not.
A: TELMIJUB AM 40/5MG TABLET may alter the blood sugar levels in your body. Therefore, it is necessary to inform your doctor if you have diabetes before taking TELMIJUB AM 40/5MG TABLET as a precaution. Your doctor will closely monitor your blood sugar levels to avoid the risk of side effects.
A: The most common side effects of taking TELMIJUB AM 40/5MG TABLET are low blood pressure, dizziness, tiredness, headache, sleepiness, swollen ankles, and flushing. Contact your doctor if any of these side effect worsens.
A: No. Do not stop taking TELMIJUB AM 40/5MG TABLET without consulting your doctor. Therefore, take TELMIJUB AM 40/5MG TABLET as advised by your doctor for the stipulated duration. Premature discontinuation of therapy may increase your blood pressure once again.
A: TELMIJUB AM 40/5MG TABLET is not recommended for use in pregnant women as it may cause serious harm to the growing fetus. Therefore, inform your doctor before taking TELMIJUB AM 40/5MG TABLET if you are pregnant, think you may be pregnant or planning to have a baby. If you become pregnant while undergoing therapy with TELMIJUB AM 40/5MG TABLET, stop taking it and consult your doctor immediately.
A: TELMIJUB AM 40/5MG TABLET should be used with caution in patients with kidney diseases (such as those having renal artery stenosis, kidney transplant or in those undergoing haemodialysis). Your doctor will access your health condition and suggest a suitable dose for you. Therefore, it is important to inform your doctor if you have any kidney problems before taking TELMIJUB AM 40/5MG TABLET as a precaution.
A: Yes. TELMIJUB AM 40/5MG TABLET may affect the way your liver work. It can elevate the levels of certain liver enzymes in your body. Therefore, it is strictly not recommended for use in patients with severe liver diseases. It should be used with caution in patients with other minor liver problems. Consult your doctor before taking it.
1. KD. Tripathi. Essentials of Medical Pharmacology. Cardiovascular Drugs. Anti-anginal and Anti-ischemic Drugs. Drugs Affecting Renin-Angiotensin system. 8th Edition. Page-595 & 537.
2. Efficacy of Combination Therapy with Telmisartan Plus Amlodipine in Patients with Poorly Controlled Hypertension. NIH. National Library of Medicine. National Center for biotechnology Information. PMC. PubMed Central. September-October 2010. [Accessed on 24th October 2024] click here
3. Amlodipine 5 and 10mg Tablet. Dr. Reddy’s Laboratories (UK) Ltd. EMC. UK. [Revised in February 2024]. [Accessed on 24th October 2024] click here
4. Telmisartan 20, 40 and 80mg. Glenmark-film coated tablet. EMC. UK. [Revised in February 2024]. [Accessed on 24th October 2024] click here
5. Telmisartan / Amlodipine Tablets. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION. [Revised in October 2023]. [Accessed on 24th October 2024] click here
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.